Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The voltage-dependent calcium channel subunit alpha2-delta2 (α2δ-2) is an auxiliary protein component of high-voltage-activated (HVA) calcium channels, encoded by the CACNA2D2 gene. It regulates calcium current density, modulates activation and inactivation kinetics, and influences trafficking and surface expression of associated calcium channels like P/Q-, N-, and L-type. It plays a role in synapse organization and, in neurons, limits axon growth/regeneration. α2δ-2 is a target for gabapentinoid drugs used to treat epilepsy and neuropathic pain.
Gabapentinoids bind to the α2δ subunits, especially isoforms 1 and 2, of voltage-dependent calcium channels, modulating calcium influx and reducing the release of excitatory neurotransmitters.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-dependent calcium channel subunit alpha2-delta2 (α2δ-2).